Antonio Campos
Overview
Explore the profile of Antonio Campos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Espana-Lopez A, Fernandez-Valades R, Cubiles E, Garzon I, Martin-Piedra M, Carriel V, et al.
BMJ Open
. 2024 Dec;
14(12):e093491.
PMID: 39638596
Introduction: The current gold standard treatment for patients with orofacial clefts is surgical repair of the palatal defect (uranostaphylorrhaphy), which is associated with growth defects and hypoplasia of the maxillofacial...
2.
Campos A, Mota C, Caramelo F, Oliveira N, Silva S, Sousa J
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274421
: To compare the prevalence of intra-ocular inflammation (IOI) between brolucizumab and aflibercept in neovascular age-related macular degeneration (nAMD) after intra-vitreal injections (IVI) and to compare the IOI odds ratios...
3.
Spanjaart A, Ljungman P, Tridello G, Schwartz J, Martinez-Cibrian N, Barba P, et al.
Leukemia
. 2024 Jul;
38(9):1985-1991.
PMID: 39043963
COVID-19 has been associated with high mortality in patients treated with Chimeric Antigen Receptor (CAR) T-cell therapy for hematologic malignancies. Here, we investigated whether the outcome has improved over time...
4.
Tomas R, Campos A, Oliveira N, Soares P, Sousa J
BMC Ophthalmol
. 2024 Mar;
24(1):123.
PMID: 38494487
Introduction: In neovascular age-related macular degeneration (nAMD) trials, anti-VEGF injection frequency decreases after the first year, while outcomes remain primarily related to the number of injections. To the best of...
5.
Martin-Piedra M, Carmona G, Campos F, Carriel V, Fernandez-Gonzalez A, Campos A, et al.
Bioeng Transl Med
. 2023 Nov;
8(6):e10572.
PMID: 38023713
A previously developed fibrin-agarose skin model-UGRSKIN-showed promising clinical results in severely burnt patients. To determine the histological parameters associated to the biocompatibility and therapeutic effects of this model, we carried...
6.
Blanco-Elices C, Oruezabal R, Sanchez-Porras D, Chato-Astrain J, Campos F, Alaminos M, et al.
Front Bioeng Biotechnol
. 2023 Aug;
11:1235161.
PMID: 37636000
Obtaining sufficient numbers of cells in a short time is a major goal of cell culturing in cell therapy and tissue engineering. However, current bidimensional (2D) culture methods are associated...
7.
Couto M, Vaz C, Branca R, Leite L, Bras G, Roncon S, et al.
Porto Biomed J
. 2023 May;
7(5):e173.
PMID: 37213920
Allogenic stem cell transplant (alloSCT) has been used for several decades as a salvage strategy for relapsed/ refractory Hodgkin lymphoma (R/R HL), being a durable disease control method for some...
8.
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, et al.
Bone Marrow Transplant
. 2023 Apr;
58(6):738.
PMID: 37076611
No abstract available.
9.
Cajas D, Guajardo E, Jara-Rosales S, Nunez C, Vargas R, Carriel V, et al.
Eur J Histochem
. 2023 Apr;
67(2).
PMID: 37052420
In humans, even where millions of spermatozoa are deposited upon ejaculation in the vagina, only a few thousand enter the uterine tube (UT). Sperm transiently adhere to the epithelial cells...
10.
Gonzalez-Gallardo C, Martinez-Atienza J, Mataix B, Munoz-Avila J, Daniel Martinez-Rodriguez J, Medialdea S, et al.
Biomed Pharmacother
. 2023 Mar;
162:114612.
PMID: 36989713
Objectives: Corneal diseases are among the main causes of blindness, with approximately 4.6 and 23 million patients worldwide suffering from bilateral and unilateral corneal blindness, respectively. The standard treatment for...